We are live on ! Find out more
SAGE

Sage Therapeutics

Delisted

SAGE was delisted on the 30th of July, 2025.

Name Holding Trade Value Shares
Change
Change in
Stake
Fidelity Investments
1
Fidelity Investments
Massachusetts
$477M +$429K +8,468 +0.1%
Vanguard Group
2
Vanguard Group
Pennsylvania
$276M -$10.8M -212,592 -4%
BlackRock
3
BlackRock
New York
$183M -$9.7M -191,457 -6%
T. Rowe Price Associates
4
T. Rowe Price Associates
Maryland
$156M -$13.2M -260,018 -9%
D.E. Shaw & Co
5
D.E. Shaw & Co
New York
$151M +$17.3M +340,910 +16%
GPP
6
Great Point Partners
Connecticut
$120M -$6.88M -135,680 -6%
Janus Henderson Group
7
Janus Henderson Group
$99M +$8.11M +160,025 +11%
BG
8
Bellevue Group
Switzerland
$96.5M +$8.31M +164,000 +12%
JP Morgan Chase
9
JP Morgan Chase
New York
$91.7M +$7.39M +145,767 +10%
Invesco
10
Invesco
Georgia
$91.4M -$12.3M -243,522 -14%
State Street
11
State Street
Massachusetts
$91M -$31.9M -628,937 -30%
Artisan Partners
12
Artisan Partners
Wisconsin
$87.6M +$11M +218,020 +18%
Citadel Advisors
13
Citadel Advisors
Florida
$87.1M -$17.2M -338,550 -19%
BC
14
Boxer Capital
California
$66.9M
Victory Capital Management
15
Victory Capital Management
Texas
$65.8M +$4.85M +95,631 +10%
FCM
16
Farallon Capital Management
California
$64.2M +$10.1M +200,000 +24%
Adage Capital Partners
17
Adage Capital Partners
Massachusetts
$57.6M +$47.7M +942,000 New
Geode Capital Management
18
Geode Capital Management
Massachusetts
$36.8M -$963K -19,000 -3%
PAI
19
Palo Alto Investors
California
$36.1M +$760K +15,000 +3%
Norges Bank
20
Norges Bank
Norway
$34.6M -$403K -7,945 -1%
Westfield Capital Management
21
Westfield Capital Management
Massachusetts
$34M -$354K -6,984 -1%
Goldman Sachs
22
Goldman Sachs
New York
$32.6M -$14.2M -279,550 -34%
Two Sigma Advisers
23
Two Sigma Advisers
New York
$32.5M -$10.2M -200,600 -27%
BCLSI
24
Bain Capital Life Sciences Investors
Massachusetts
$30.5M
UBS AM
25
UBS AM
Illinois
$27.2M +$230K +4,529 +1%